|
IPHA Innate Pharma SA 1598599 |
| Balance Sheet |
|
Current Assets
|
$46,710,000.00 |
|
Assets
|
$62,719,000.00 |
|
Current Liabilities
|
$36,649,000.00 |
|
Equity
|
$-21,704,000.00 |
|
Shares Out
|
93719323.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-52,755,000.00 |
|
Investing Cash Flow
|
$7,289,000.00 |
| Market Analysis |
Market Cap
|
$164,008,815.25 |
|
Price
|
$1.71 |
|
PB
|
0.76 |
|
EPS
|
-0.62 |
|
PS
|
18.73 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:35 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:33 |
|
| Apr |
May |
Jun |
| 2026-03-26 |
-0.55 |
|
|
2026-05-13 |
|
|
| Oct |
Nov |
Dec |
| 2025-09-17 |
|
|
|
2025-11-13 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view IPHA documents filed with the SEC.
IPHA Filings
Clear
